Securities code: Honz Pharmaceutical Co.Ltd(300086) securities abbreviation: Honz Pharmaceutical Co.Ltd(300086) Announcement No.: 2022017 Honz Pharmaceutical Co.Ltd(300086)
Announcement on the company's profit distribution plan for 2021
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
On April 6, 2022, the 23rd Meeting of the 5th board of directors and the 18th meeting of the 5th board of supervisors of Honz Pharmaceutical Co.Ltd(300086) (hereinafter referred to as "the company") deliberated and adopted the company's 2021 profit distribution plan. This proposal still needs to be submitted to the company's 2021 annual general meeting for deliberation. The relevant information is hereby announced as follows:
1、 2021 profit distribution plan
Audited by Zhongshen Zhonghuan Certified Public Accountants (special general partner), the net profit of Honz Pharmaceutical Co.Ltd(300086) (parent company) in 2021 was 1098750499 yuan. As of December 31, 2021, the profit available for distribution to shareholders of the company was 10165732776 yuan.
In accordance with the guidelines for the supervision of listed companies No. 3 - cash dividends of listed companies and the articles of association and other relevant provisions, taking into account the company's future development needs and in combination with the company's operation and cash flow, the board of directors of the company puts forward the following plans for the company's profit distribution plan in 2021:
In 2021, the company plans not to make profit distribution, nor to convert capital reserve into share capital or send shares. 2、 Reasons for no profit distribution in 2021
According to the actual operating results of the company in 2021 and the business operation and investment development plan in 2022, the company plans to use the net profit in 2021 to support the business operation and investment development of the company, so as to expand its main business. 3、 Purpose and use plan of undistributed profits of the company
The company's undistributed profits in 2021 will be accumulated and rolled over to the next year to meet the working capital needs brought by the company's daily operation and provide a reliable guarantee for the smooth implementation of the company's medium and long-term development strategy and healthy and sustainable development. In accordance with the provisions of the articles of association, the company will strictly consider the distribution of profits and returns in the form of comprehensive consideration of the company's development, and strictly implement the relevant laws and regulations, such as the company's profit distribution and return, in accordance with the company's development rules, in accordance with the relevant laws and regulations.
4、 Opinions of the board of directors
The 23rd Meeting of the 5th board of directors of the company deliberated and approved the 2021 annual profit distribution plan of the company, and agreed to submit the proposal to the 2021 annual general meeting of shareholders of the company for deliberation.
5、 Opinions of the board of supervisors
The 18th meeting of the 5th board of supervisors of the company deliberated and approved the 2021 annual profit distribution plan of the company. The board of supervisors believes that after review, the board of supervisors believes that the company's profit distribution plan for 2021 proposed by the board of directors is in line with the company's current actual business situation, conducive to the sustainable and stable development of the company, and there is no damage to the interests of the company and all shareholders. Agree to submit the proposal to the general meeting of shareholders of the company for deliberation.
6、 Opinions of independent directors
The independent directors of the company believe that the profit distribution plan of the company in 2021 is in line with the current actual situation of the company, conducive to the sustainable and stable development of the company, and there is no harm to the interests of all shareholders, especially small and medium-sized investors. Therefore, we agree with the profit distribution plan of the company and agree to submit the proposal to the general meeting of shareholders for deliberation.
It is hereby announced.
Honz Pharmaceutical Co.Ltd(300086)
Board of directors
April 6, 2022
